×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  
data?.title

Navigating a Reopening in Health Care

June 1, 2022

ClearBridge Investments · Can the Fed Engineer a Soft Landing?

Health Care Analyst Marshall Gordon and Portfolio Manager Jean Yu join Jeff Schulze to discuss the macro headwinds facing the health care sector and why they are favoring larger cap companies in a volatile equity market.

Related Perspectives

Crude Helped, Chips Hurt
Value 3Q26: We are maintaining measured exposure to AI leaders while emphasizing diversification among attractively valued, durable businesses in overlooked sectors.
Upgrading AI Exposures for Next Leg of Growth
Global Growth 3Q26: We view the AI-led momentum selloff as sentiment driven and remain constructive on the technology’s long-term potential while diversifying exposures, managing risk and positioning for broader enterprise adoption.
Disciplined Approach to AI Provides Resilience
Large Cap Growth 3Q26: The Strategy’s focus on quality and valuation proved beneficial in a volatile period for higher beta growth stocks.
Diversification More Important Than Ever
Dividend Strategy 3Q26: We are maintaining measured exposure to AI leaders while emphasizing diversification among attractively valued, durable businesses in overlooked sectors.
Stock Selection Shines Through Growth Reset
SMID Cap Growth 3Q26: A volatile quarter reset expectations across SMID growth, with investors increasingly rewarding quality, execution and free cash flow discipline.
More
  • Copyright © 2022 ClearBridge investments. 

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

  • Performance source: Internal. Benchmark source: Standard & Poor's.

  • Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2026. FTSE Russell is a trading name of certain of the LSE Group companies. “Russell®” is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

more